Home >> Tag Archives: ScyTek Laboratories—

Tag Archives: ScyTek Laboratories—

Multiplex TTF-1 and cytokeratin 5 cocktail, 3/16

March 2016—ScyTek Laboratories announced the availability of its Multiplex TTF-1 and Cytokeratin 5 Cocktail. This multiplex cocktail of TTF-1 and cytokeratin 5 produces two-color, high-contrast staining for differentiating primary adenocarcinoma of the lung from metastatic carcinomas of the breast and malignant mesothelioma. This cocktail can increase sensitivity and diagnostic utility in differential diagnosis of the tumor.

Read More »

Scytek offers cocktail antibody for lung cancer Dx

Jan. 19, 2016—ScyTek Laboratories announced the availability of multiplex TTF-1 and cytokeratin 5 cocktail. This cocktail is designed to increase sensitivity and diagnostic utility in differential diagnosis of the tumor. TTF-1 is a nuclear protein originally identified in thyroid epithelial cells, a known mediator of thyroid specific gene transcription and activator of thyroglobulin and thyroperoxidase. TTF-1 is retained in 80 ...

Read More »
X